BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Zhu W, Biskup E, Yang W, Yang Z, Wang H, Qiu X, Zhang C, Hu G, Hu G. Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data. J Bone Oncol 2018;11:38-50. [PMID: 29511626 DOI: 10.1016/j.jbo.2018.01.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ma Y, Jiang L, Hu J, Zhu E, Zhang N. Developing a Versatile Multiscale Therapeutic Platform for Osteosarcoma Synergistic Photothermo-Chemotherapy with Effective Osteogenicity and Antibacterial Capability. ACS Appl Mater Interfaces 2022. [PMID: 36125961 DOI: 10.1021/acsami.2c10772] [Reference Citation Analysis]
2 Liu WC, Li MX, Wu SN, Tong WL, Li AA, Sun BL, Liu ZL, Liu JM. Using Machine Learning Methods to Predict Bone Metastases in Breast Infiltrating Ductal Carcinoma Patients. Front Public Health 2022;10:922510. [PMID: 35875050 DOI: 10.3389/fpubh.2022.922510] [Reference Citation Analysis]
3 Zou B, Xiong Z, He L, Chen T. Reversing breast cancer bone metastasis by metal organic framework-capped nanotherapeutics via suppressing osteoclastogenesis. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jacobson D, Cadieux B, Higano CS, Henry DH, Bachmann BA, Rehn M, Stopeck AT, Saad H. Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach. Journal of Bone Oncology 2022. [DOI: 10.1016/j.jbo.2022.100423] [Reference Citation Analysis]
5 Shao H, Varamini P. Breast Cancer Bone Metastasis: A Narrative Review of Emerging Targeted Drug Delivery Systems. Cells 2022;11:388. [PMID: 35159207 DOI: 10.3390/cells11030388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Hu X, Huang W, Sun Z, Ye H, Man K, Wang Q, Sun Y, Yan W. Predictive factors, preventive implications, and personalized surgical strategies for bone metastasis from lung cancer: population-based approach with a comprehensive cancer center-based study. EPMA Journal. [DOI: 10.1007/s13167-022-00270-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Deng J, Zhang D, Zhang W, Li J. Construction and Validation of New Nomograms to Predict Risk and Prognostic Factors of Breast Cancer Bone Metastasis in Asian Females: A Population-Based Retrospective Study. Int J Gen Med 2021;14:8881-902. [PMID: 34866932 DOI: 10.2147/IJGM.S335123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Trivedi T, Pagnotti GM, Guise TA, Mohammad KS. The Role of TGF-β in Bone Metastases. Biomolecules 2021;11:1643. [PMID: 34827641 DOI: 10.3390/biom11111643] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
9 Sakisuka T, Kashiwagi N, Doi H, Takahashi H, Arisawa A, Matsuo C, Masuda Y, Inohara H, Sato K, Outani H, Ishii K, Tomiyama N. Prognostic factors for bone metastases from head and neck squamous cell carcinoma: A case series of 97 patients. Mol Clin Oncol 2021;15:246. [PMID: 34650813 DOI: 10.3892/mco.2021.2408] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Othman A, Winogradzki M, Lee L, Tandon M, Blank A, Pratap J. Bone Metastatic Breast Cancer: Advances in Cell Signaling and Autophagy Related Mechanisms. Cancers (Basel) 2021;13:4310. [PMID: 34503118 DOI: 10.3390/cancers13174310] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Puppo M, Valluru MK, Clézardin P. MicroRNAs and Their Roles in Breast Cancer Bone Metastasis. Curr Osteoporos Rep 2021;19:256-63. [PMID: 33830428 DOI: 10.1007/s11914-021-00677-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Bongiovanni A, Foca F, Fantini M, Forcignanò MR, Artioli F, Berardi R, Campadelli E, Procopio G, Silvestris F, Riva N, Gurrieri L, Debonis SA, Di Menna G, Fausti V, Recine F, Vespignani R, Ibrahim T. First prospective data on breast cancer patients from the multicentre italian bone metastasis database. Sci Rep 2021;11:4329. [PMID: 33619285 DOI: 10.1038/s41598-021-83749-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Huang Z, Hu C, Liu K, Yuan L, Li Y, Zhao C, Hu C. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study. BMC Cancer 2020;20:1145. [PMID: 33238981 DOI: 10.1186/s12885-020-07635-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kanda Y, Kakutani K, Yurube T, Zhang Z, Miyazaki S, Kakiuchi Y, Takeoka Y, Tsujimoto R, Miyazaki K, Kawamoto T, Takada T, Hoshino Y, Tabata Y, Kuroda R. A novel topical treatment for bone metastases using a gelatin hydrogel incorporating cisplatin as a sustained release system. J Orthop Res 2021;39:525-35. [PMID: 33030789 DOI: 10.1002/jor.24874] [Reference Citation Analysis]
15 Guerrieri AN, Montesi M, Sprio S, Laranga R, Mercatali L, Tampieri A, Donati DM, Lucarelli E. Innovative Options for Bone Metastasis Treatment: An Extensive Analysis on Biomaterials-Based Strategies for Orthopedic Surgeons. Front Bioeng Biotechnol 2020;8:589964. [PMID: 33123519 DOI: 10.3389/fbioe.2020.589964] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
16 Møller AMJ, Delaisse JM, Olesen JB, Bechmann T, Madsen JS, Søe K. Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals. JBMR Plus 2020;4:e10412. [PMID: 33210064 DOI: 10.1002/jbm4.10412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Carminati L, Taraboletti G. Thrombospondins in bone remodeling and metastatic bone disease. Am J Physiol Cell Physiol 2020;319:C980-90. [PMID: 32936697 DOI: 10.1152/ajpcell.00383.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Zhang L, Zhang J, Li Z, Wu Y, Tong Z. Comparison of the clinicopathological characteristics and prognosis between Chinese patients with breast cancer with bone-only and non-bone-only metastasis. Oncol Lett 2020;20:92. [PMID: 32831911 DOI: 10.3892/ol.2020.11953] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Zhang Z, Yao Y, Yuan Q, Lu C, Zhang X, Yuan J, Hou K, Zhang C, Du Z, Gao X, Chen X. Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis. Theranostics 2020;10:4042-55. [PMID: 32226538 DOI: 10.7150/thno.42218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
20 Zhao P, Ge Y, Liu X, Ke Q, Zhang J, Zhu Z, Guo Y. Ordered arrangement of hydrated GdPO4 nanorods in magnetic chitosan matrix promotes tumor photothermal therapy and bone regeneration against breast cancer bone metastases. Chemical Engineering Journal 2020;381:122694. [DOI: 10.1016/j.cej.2019.122694] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
21 Chuang WC, Tsang NM, Chuang CC, Chang KP, Pai PC, Chen KH, Chou WC, Tai SF, Liu SC, Lei KF. Association of subcutaneous and visceral adipose tissue with overall survival in Taiwanese patients with bone metastases - results from a retrospective analysis of consecutively collected data. PLoS One 2020;15:e0228360. [PMID: 31999771 DOI: 10.1371/journal.pone.0228360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Yang S, Liu H, Zhu L, Li X, Liu D, Song X, Yokota H, Zhang P. Ankle loading ameliorates bone loss from breast cancer–associated bone metastasis. FASEB j 2019;33:10742-52. [DOI: 10.1096/fj.201900306rr] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
23 Sturgeon KM, Mathis KM, Rogers CJ, Schmitz KH, Waning DL. Cancer- and Chemotherapy-Induced Musculoskeletal Degradation. JBMR Plus 2019;3:e10187. [PMID: 30918923 DOI: 10.1002/jbm4.10187] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
24 Zhao C, Lou Y, Wang Y, Wang D, Tang L, Gao X, Zhang K, Xu W, Liu T, Xiao J. A gene expression signature-based nomogram model in prediction of breast cancer bone metastases. Cancer Med 2019;8:200-8. [PMID: 30575323 DOI: 10.1002/cam4.1932] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
25 Cuperjani F, Gashi L, Kurshumliu F, Dreshaj S, Selimi F. Relationship between Ribosomal Protein S6-pS240 Expression and other Prognostic Factors in Non-Special Type Invasive Breast Cancer. Breast Care (Basel) 2019;14:171-5. [PMID: 31316316 DOI: 10.1159/000491427] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 McGrath LJ, Overman RA, Reams D, Cetin K, Liede A, Narod SA, Brookhart MA, Hernandez RK. Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US. Clin Epidemiol 2018;10:1349-58. [PMID: 30288124 DOI: 10.2147/CLEP.S175063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]